Literature DB >> 12744848

Hepatitis A: post-exposure prophylaxis.

Gloria Taliani1, Giovanni Battista Gaeta.   

Abstract

We report on the findings of an exploratory review of evidence published in English from 1945 to identify the best post-exposure prophylaxis treatment and the longest acceptable interval after exposure for prophylaxis to be effective. We found no evidence that post-exposure administration of currently available immunoglobulins is effective in preventing hepatitis A infection and disease. The use of immunoglobulins for immunoprophylaxis should not be widely recommended until a systematic review of the evidence has been conducted. We recommend that active immunization to secondary contacts of exposed and vaccinated subjects be offered.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12744848     DOI: 10.1016/s0264-410x(03)00138-5

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Effectiveness of hepatitis A vaccination as post-exposure prophylaxis.

Authors:  Ignasi Parrón; Caritat Planas; Pere Godoy; Sandra Manzanares-Laya; Ana Martínez; Maria Rosa Sala; Sofia Minguell; Nuria Torner; Mireia Jané; Angela Domínguez
Journal:  Hum Vaccin Immunother       Date:  2016-12-07       Impact factor: 3.452

2.  Hepatitis a and e infection in international travellers.

Authors:  Joseph Torresi; Douglas Johnson
Journal:  Curr Infect Dis Rep       Date:  2011-06       Impact factor: 3.725

3.  An outbreak of hepatitis A among children and adults in Denmark, August 2002 to February 2003.

Authors:  A Gervelmeyer; M Søborg Nielsen; L Chemnitz Frey; H Sckerl; E Damberg; K Mølbak
Journal:  Epidemiol Infect       Date:  2005-09-30       Impact factor: 2.451

4.  Long-term protective effect of post-exposure Havrix administration during viral hepatitis Type A outbreaks.

Authors:  I Kohl; V Nemecek; M Summerová; R Chlíbek; K Nad'ová; O Mináriková
Journal:  Eur J Epidemiol       Date:  2006-12-08       Impact factor: 8.082

5.  [Prevention and therapy of viral hepatitis].

Authors:  H M Diepolder
Journal:  Internist (Berl)       Date:  2004-02       Impact factor: 0.743

6.  A retrospective pooled analysis assessing the effect of age on the immunogenicity of Havrix™ in healthy adults.

Authors:  Olivier Van Der Meeren; Priya Crasta; Marc de Ridder
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

7.  Evaluation of hepatitis A vaccine in post-exposure prophylaxis, The Netherlands, 2004-2012.

Authors:  Jane Whelan; Gerard J Sonder; Lian Bovée; Arjen Speksnijder; Anneke van den Hoek
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.